Successful treatment of COVID‐19 infection with convalescent plasma in B‐cell‐depleted patients may promote cellular immunity

Treatment with convalescent plasma has been shown to be safe in coronavirus disease in 2019 (COVID‐19) infection, although efficacy reported in immunocompetent patients varies. Nevertheless, neutralizing antibodies are a key requisite in the fight against viral infections. Patients depleted of antib...

Descripción completa

Detalles Bibliográficos
Autores principales: Kremer, Andreas E., Kremer, Anita N., Willam, Carsten, Völkl, Simon, Verhagen, Johan, Achenbach, Susanne, van der Meijden, Edith D., Lang, Vanessa, Aigner, Michael, Maier, Clara, Tenbusch, Matthias, Korn, Klaus, Lutzny‐Geier, Gloria, Spoerl, Silvia, Strauß, Richard, Vetter, Marcel, Überla, Klaus, Neurath, Markus F., Mackensen, Andreas, Schiffer, Mario, Hackstein, Holger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Immunity to infection
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420096/
https://www.ncbi.nlm.nih.gov/pubmed/34350584
http://dx.doi.org/10.1002/eji.202149277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420096/
https://www.ncbi.nlm.nih.gov/pubmed/34350584
http://dx.doi.org/10.1002/eji.202149277

Ejemplares similares